Mirum Pharmaceuticals Inc.

04/26/2021 | Press release | Distributed by Public on 04/26/2021 07:14

Mirum Pharmaceuticals Receives Notice of Allowance for Methods of Use Patent for Maralixibat in Alagille Syndrome